, Situation de la chimiothérapie des cancers-Année, 2014.

, Bonnes pratiques de fabrication, 2016.

, Adaptations des ressources liées à la pharmacie oncologique-Recommandation n°13. 2012. En ligne

V. Cohen-s, C. Rc, G. B. Mcmanus-r, C. K. Scheckelhoff-k, D. At et al.,

, Am J Health Syst Pharm, vol.69, issue.18, 2012.

S. , A. A. Ehmann-m, M. M. Ober-m, and H. , Semiautomated aseptic preparation of patient individual antineoplastic intravenous solutions: First experiences in a German hospital pharmacy

, Eur J Hosp Pharm, vol.23, pp.44-49, 2016.

R. Salles-g, S. Hm, . Schwiertz-v, P. S. Vantard-n, B. F. et al., Chemotherapeutic errors in hospitalised cancer patients: Attributable damage and extra costs, BMC Cancer, 2011.

C. White-r, . Fields-a, and E. Cheng-r, Intravenous chemotherapy preparation errors: Patient safety risks identified in a pan-Canadian exploratory study

, J Oncol Pharm Pract, vol.20, issue.1, pp.40-46, 2014.

C. Mantin-r, B. G. Shen-y-m, and . Sussman-h, Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management. Cancer, vol.72, pp.3707-3721, 1993.

M. Me, C. Aj, L. O. Wd, E. Mj, and . Batley-r, Inadvertent intrathecal injection of daunorubicin with fatal outcome

, Med Pediatr Oncol, vol.20, issue.3, pp.249-53, 1992.

W. Me, W. An, J. P. Bracikowski, G. L. , W. Kd et al., Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapic error. Cancer, vol.51, pp.2041-2048, 1983.

M. T. Iwamoto-t, H. M. Sudo, H. , and P. D. Okuda-m, Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital

, J Pharm Health Care Sci, vol.3, 2017.

R. Fricker-jr-m and C. Levine-s, Guidelines for the safe preparation of sterile compounds: Results of the ISMP sterile preparation compounding safety summit of, 2011.

, Hosp Pharm, vol.48, issue.4, pp.282-294, 2013.

B. J. , GHS automates sterile IV compounding, 2014.

. Vazquez-r, G. Boubet-k, and C. , Impact of handling errors for chemical cross-contamination risk for the preparation of parenteral cytotoxic drugs, Pharm Technol Hosp Pharm, vol.1, issue.3, 2016.

P. Lb, E. Savage-sw, and . Sf, Assessment of final product dosing accuracy when using volumetric technique in the preparation of chemotherapy, J Oncol Pharm Pract, vol.22, issue.1, pp.3-9, 2016.

G. , Cytotoxic surface contamination in a robotic system compared with manual preparation

, Eur J Hosp Pharm, vol.19, 2012.

A. , J. M. , C. , and B. Batista-r, Evaluation de la contamination chimique lors de la préparation des chimiothérapies en isolateur et sur le robot Kiro Oncology®

C. , The Cytocare robot in reconstitution of cytotoxics-A way to reduce contamination ? European Association of Hospital Pharmacists. Avril, 2009.

S. Ac, C. Ww, K. Ca, B. Cd, W. St et al., Impact of robotic antineoplastic preparation on safety, workflow, and costs, J Oncol Pract, vol.8, issue.6, 2012.

P. E. Bufarini-c, Robot-assisted preparation of oncology drugs: The role of nurses

J. Int and . Pharm, , vol.439, 2012.

S. Masini-c, G. S. , F. E. Bohlandt-a, R. V. , and P. , Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo, J Oncol Pharm Pract, vol.22, issue.1, 2016.

K. and F. M. Schierl-r, Environmental and product contamination during the preparation of antineoplastic drugs with robotic systems. Pharm Technol Hosp Pharm. 2018 ahead of print

, AST74. Troubles musculo-squelettiques. En ligne

A. , G. A. , and C. , Méthode de prévention des troubles musculosquelettiques du membre supérieur et outils simples. Documents pour le médecin du travail, vol.83, pp.187-194, 2000.

L. C. , Le robot assistant-pharmacien

R. , G. , F. K. Bourbon, J. , and G. , Prévention des troubles musculo squelettiques en pharmacotechnie

M. C. , M. G. Sankhare-d, F. P. Levert, H. , and J. N. , Préparation en lots d'une spécialité à reconstituer : cas du cyclophosphamide

T. , T. E. Van-hollebeke-m, J. M. , S. V. , and C. , Perception de la pénibilité au travail en unité de pharmacotechnie : Evaluation de l'impact de l'automatisation de la préparation de poches de nutrition parentérale

G. B. , Automates de production de chimiothérapies: analyse du marché en France et considérations préalables à une installation, 2015.

M. , N. O. , A. S. , G. D. , M. M. et al., Automated preparation of chemotherapy: Quality improvement and economic sustainability

, Am J Health Syst Pharm, vol.71, issue.7, 2014.

G. J. , Etude de faisabilité de la mise en place d'automates pour la préparation des chimiothérapies au sein des unités de reconstitution des cytotoxiques de l'assistance publique des hôpitaux de Marseille

. Thèse-d'exercice and . Marseille, , 2017.

Y. Aw, . Orsborn-a, J. J. Bonkowski, K. I. Chew-l, C. et al.,

J. Am and . Pharm, , vol.74, 2017.

S. , D. C. , L. N. , P. C. , and H. ,

, Implémentation d'un robot pour la préparation de médicaments intraveineux dans un service de pharmacie

Y. Aw and K. Sj, Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy

, Am J Health Syst Pharm, vol.70, issue.22, pp.2030-2037, 2013.

H. , D. C. , L. N. , and P. C. Soumoy-l, Revue de la reconstitution manuelle et automatique des médicaments intraveineux : une mise à jour en 2017

F. Kabi,

, Health Robotics : présentation du robot i.v. Station®. En ligne

, Loccioni Humancare : présentation du robot APOTECA®. En ligne

, Kiro Grifols : présentation du robot KIRO® Oncology

. Arxium,

. Stäubli and . La-robotique.-en-ligne,

V. , C. L. , F. L. , and B. L. Bonnabry-p, Evaluation des performances de l'automate PharmaHelp pour la production de poches injectables de cytotoxiques, 2015.

S. Pjm, L. Gm, W. , H. L. , H. C. et al., Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation

, J Oncol Pharm Pract, vol.21, issue.2, 2015.

J. Rk, Five year's experience with a compounding robot

, EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use. Annex 15: Qualification and Validation, 2015.

P. Européenne, , 2017.

P. Américaine, , 2018.

, EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use. Annex 1: Manufacture of sterile medicinal products, 2008.

, International Organization of Standardization. ISO 14644-1:2015-Cleanrooms and associated controlled environments, 2015.

. Pharmacopée, Méthodes biologiques (2.6). 9 ème édition, 2017.

, International Organization of Standardization. ISO 13408-1:2008-Aseptic processing of health care products-Part 1: General requirements, 2008.

, ISOPP Standards of Practice. Section 4-Education and training, 2007.

M. F. , Media fill validation for automated compounding devices

, Pharmaceutical Inspection Co-operation Scheme, 2011.

K. , F. M. , K. V. , and T. , Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes, J Oncol Pharm Pract, vol.22, issue.2, pp.195-204, 2016.

W. Tk and . Oby-c, Media fill to validate the aseptic preparation of cytotoxics on an automated robot

, Eur J Hosp Pharm Sci Pract, vol.21, 2014.

B. , M. A. , G. S. , R. V. , and P. , Aseptic processing validation of the IV compounding robot in a hospital pharmacy

I. Congrès and . Xiv, International Symposium on Oncology Pharmacy Practice). Avril, 2014.

S. , F. M. Vazquez-r, G. Mn, and C. Brossard-d, Aseptic simulation test challenged with microorganisms for validation of pharmacy operators, Am J Health Syst Pharm, vol.69, issue.14, 2012.

L. F. , Stratégie de validation des procédés de nettoyage des équipements de production en industrie pharmaceutique. A3P Rev "La Vague

C. Lopez-c, O. M. , C. G. , and T. , Cytotoxic contamination level follow-up during the implementation of an automated compounding system

T. Mj and C. G. Goldberg-l, The validation of an automated self-cleaning process in a new robot for the preparation of cytotoxic drugs

, Recommendations on validation master plan, installation and operational qualification, non-sterile process validation, cleaning validation, 2007.

. Pharmacopée, Essai du volume extractible pour les préparations parentérales (2.9.17). 9 ème édition, 2017.

S. Rg, Solubilizing excipients in oral and injectable formulations, Pharm Res, vol.21, issue.2, pp.201-231, 2004.

E. Fk, M. Raa, and V. , Alternative drug formulations of docetaxel: a review, Anticancer Drugs, vol.18, issue.2, pp.95-103, 2007.

S. Pj, C. Wg, and C. Cg, Handbook of pharmaceutical excipients, 2017.

G. Dumoulin-c, Automate de fabrication des anticancéreux injectables: qualification opérationnelle, 2011.

J. , B. , H. A. , E. L. , and C. , Evaluation des performances du robot Kiro Oncology® pour la préparation de poches, seringues et diffuseurs portables d'anticancéreux

G. Èmes-journées-du and . Octobre, Presqu'île de Giens, 2016.

T. Vrn, T. , M. Hb, and G. Al, Viscosity of aqueous carbohydrate solutions at different temperatures and concentrations

, Int J Food Prop, vol.10, issue.1, pp.185-195, 2007.

C. , M. V. , V. As, and F. P. Bouchoud-l, Qualification and performance evaluation of an automated system for compounding injectable cytotoxic drugs. Pharm Technol Hosp Pharm. 2018 ahead of print

. King-guide-publications, Total parenteral nutrition solutions, 2003.

P. Bjm, C. Mah, A. T. , V. De, and . Emw, Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab)

, MAbs, vol.5, issue.1, 2013.

. Power-l, G. K. Sessink-p, and . Charbonneau-f, Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process

, Hosp Pharm, vol.49, issue.4, 2014.

, Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Q2(R1) : Validation of analytical procedures: Text and methodology, 2015.

, Adaptations des ressources liées à la pharmacie oncologique-Recommandation n°20. 2012. En ligne

A. European-medicines, Guideline on process validation for finished products-Information and data to be provided in regulatory submissions, 2016.

L. F. , Centrally prepared cytotoxic drugs: what is the purpose of their quality control ? Pharm Technol Hosp Pharm, vol.2, 2017.

, A standard protocol for deriving and assessment of stability-Part 2: Aseptic Preparations (biopharmaceuticals), 2017.

C. Bouchoud-l, F. , C. C. , F. L. Sadeghipour-f, and . Bonnabry-p, Reliability of chemotherapy preparation processes: Evaluating independent double-checking and computerassisted gravimetric control

, J Oncol Pharm Pract, vol.23, issue.2, 2017.

C. Wh, G. Shen-lj, L. Rj, and . Wu-fl, Assessment of an automatic robotic arm for dispensing of chemotherapy in a 2500-bed medical center, J Formos Med Assoc, vol.112, issue.4, 2013.

N. Fares-d, M. M. , V. A. , A. Ewing-s, A. M. et al., A three-year study of a first-generation chemotherapy-compounding robot

, Am J Health Syst Pharm, vol.72, issue.12, 2015.

P. Rj and . Sewell-gj, Dose-banding of cytotoxic drugs: a new concept in cancer chemotherapy

, Am J Health Syst Pharm, vol.58, issue.18, pp.1760-1764, 2001.

W. D. , Risks and rewards on the road to IV automation, 2018.

E. Imlah, C. , and H. K. Trozzo-p, Robotic IV Compounding : The Manitoba Experience

P. Al, E. L. , J. N. , C. P. , F. P. et al., Dose standardisation of anticancer drugs

, Int J Clin Pharm, vol.33, issue.2, 2011.

, Annexe 13-Mode opératoire utilisé pour l'évaluation de la fiabilité du contrôle gravimétrique (1/3 étape de reconstitution des flacons)

, Annexe 14-Mode opératoire utilisé pour l'évaluation de la fiabilité du contrôle gravimétrique (2/3 étape de prélèvement de dose)

, Annexe 15-Mode opératoire utilisé pour l

, Moyenne-3.83% 384, p.48

, Maximum-6.67% 398, p.29

S. De-galien-je-jure, en présence des maîtres de la Faculté, des conseillers de l'ordre des Pharmaciens et de mes condisciples : D'honorer ceux qui m'ont instruit dans les préceptes de mon art et de leur témoigner ma reconnaissance en restant fidèle à leur enseignement

, intérêt de la santé publique, ma profession avec conscience et de respecter non seulement la législation en vigueur, mais aussi les règles de l'honneur

, En aucun cas, je ne consentirai à utiliser mes connaissances et mon état pour corrompre les moeurs et favoriser des actes criminels

, Que les hommes m'accordent leur estime si je suis fidèle à mes promesses

, Que je sois couvert d'opprobre et méprisé de mes confrères si j'y manque